Back to Search
DR. MELISSA RAE REILY M.D.
M.D.
Rheumatology Physician
NPI: 1003090481IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
MD61585353(WA)77226(MN)18608(MT)
Education
OTHER
Class of 2006
Research & Publications (20)
Normalization strategies for metabonomic analysis of urine samples.
PMID 19185549·J Chromatogr B Analyt Technol Biomed Life Sci·2009
7-preclinical
Quantitative evaluation of sebum lipid components with nuclear magnetic resonance.
PMID 18094397·J Lipid Res·2008
7-preclinical
Metabonomic evaluation of metabolic dysregulation in rats induced by PF 376304, a novel inhibitor of phosphoinositide 3-kinase.
PMID 18001061·Chem Res Toxicol·2007
7-preclinical
Heteronuclear 1H-31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: application to galactosamine-induced hepatotoxicity.
PMID 17973499·Anal Chem·2007
7-preclinical
Improving NMR sensitivity by use of salt-tolerant cryogenically cooled probes.
PMID 17206512·Anal Bioanal Chem·2007
8-other
Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
PMID 17536843·Chem Res Toxicol·2007
7-preclinical
The mechanism of galactosamine toxicity revisited; a metabonomic study.
PMID 17580851·J Proteome Res·2007
7-preclinical
Metabonomic evaluation of Schaedler altered microflora rats.
PMID 17900170·Chem Res Toxicol·2007
4-observational
DFTMP, an NMR reagent for assessing the near-neutral pH of biological samples.
PMID 16984154·J Am Chem Soc·2006
7-preclinical
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.
PMID 16362036·EMBO J·2006
7-preclinical
Communication regarding metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats.
PMID 16484286·Toxicol Sci·2006
7-preclinical
Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat.
PMID 16537294·Toxicol Pathol·2006
7-preclinical
Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats.
PMID 15933226·Toxicol Sci·2005
7-preclinical
Summary recommendations for standardization and reporting of metabolic analyses.
PMID 16003371·Nat Biotechnol·2005
6-review
Metabonomics in preclinical drug development.
PMID 16863449·Expert Opin Drug Metab Toxicol·2005
6-review
Estimation of weights for various methods of the fitting of equilibrium data from the analytical ultracentrifuge.
PMID 15081690·Methods Enzymol·2004
7-preclinical
Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
PMID 15155556·Drug Metab Dispos·2004
7-preclinical
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.
PMID 12662897·Toxicol Appl Pharmacol·2003
7-preclinical
Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats.
PMID 12387750·Toxicol Appl Pharmacol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 931 HIGHLAND BLVD STE 3260
BOZEMAN, MT 59715 - Phone
- (406) 414-2410
Quick Facts
- NPI
- 1003090481
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile